Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Cipla, Lupin, M&M Financial Services: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Cipla, Lupin and M&M Financial Services.

    • Buy, sell, hold: 10 crucial stocks to watch out post Q3 results

      While retaining overweight rating with increased target price at Rs 185 (from Rs 180 earlier), JPMorgan expects NTPC to close the acquisition of phase-I of Chhabra plant by March. Inorganic growth plan are EPS accretive, it feels.

    • Buy, sell, hold: 7 stocks analysts are watching out

      Morgan Stanley also says Jubilant Foodworks' earnings are ahead of estimates and there was impressive cost control. It is best placed to capitalise on urban consumption recovery, it feels. The research firm is overweight on the Stock, with a target price at Rs 1,230.

    • Buy Hindustan Unilever, Cipla: Rahul Mohindar

      According to Rahul Mohindar of viratechindia.com, one can buy Hindustan Unilever and Cipla.

    • Buy Sintex Industries, Cipla: Sandeep Wagle

      Sandeep Wagle of powermywealth.com suggests buying Sintex Industries and Cipla.

    • Sell Strides Shasun, Cipla; buy Tata Communications: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may sell Strides Shasun and Cipla and buy Tata Communications.

    • Sell Glenmark; buy Cipla, Cummins, AIA Engineering: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can sell Glenmark Pharma and buy Cipla, Cummins India and AIA Engineering.

    • Buy Tata Communications 680 Call, sell 720 Call: VK Sharma

      VK Sharma, Head of Business, Private Client Group at HDFC Securities is of the view that one may buy Tata Communications 680 Call, sell 720 Call while one can buy Torrent Power 185 Call.

    • Top buzzing stocks to trade on January 12

      Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.

    • Buy, sell, hold: 14 stocks that you can focus today

      Credit Suisse stays outperform rating on L&T and Sadbhav Engineering. It has outperform rating on L&T on pick-up in domestic execution, strong earnings growth.

    • Buy, sell, hold: 9 pharma & media stocks that you may focus

      Citi upgrades Sun TV to buy and Zee Entertainment to neutral. It prefers Dish TV at current valuations, retaining buy call on the stock.

    • Here are Deven Choksey's top trading ideas

      In an interview to CNBC-TV18 Deven Choksey, MD at KRChoksey Investment Managers shared his reading and outlook on the market.

    • Buy BHEL, Asian Paints; stay away from Cipla: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying BHEL and Asian Paints and advises staying away from Cipla.

    • Here is why SP Tulsian continues to be positive on market

      Despite the recent fall in market, SP Tulsian of sptulsian.com maintains his positive stance on back of expectation of a good Budget.

    • Sell HDFC Bank, Cipla: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling HDFC Bank with a target of Rs 1150 and Cipla with a target of Rs 546.

    • Sell IndusInd Bank, DCB Bank, Cipla: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends selling IndusInd Bank, DCB Bank and Cipla and has a target of Rs 20400 on Eicher Motors.

    • Buy Adani Ports, Tata Elxsi; sell Tata Steel: Ashwani Gujral

      Ashwani Gujral, Fund Manager at ashwanigujral.com recommends buying Adani Ports and Tata Elxsi and advises selling Tata Steel.

    • Buy Coffee Day, Cipla; sell India Cements, DHFL: Gujral

      Ashwani Gujral, Fund Manager at ashwanigujral.com is of the view that one can buy Coffee Day and Cipla and sell India Cements, DHFL and L&T Finance Holdings.

    • Buy Tech Mahindra, JSW Steel, Cipla: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, one may buy Tech Mahindra, JSW Steel, Cipla and Hindustan Petroleum Corporation.

    • Sell Eicher Motors; buy Cipla, Sonata Software: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Cipla and Sonata Software.

    • Buy, sell, hold: 5 stocks that analysts are watching out

      Bank of America Merrill Lynch maintains buy rating on Zee Entertainment with a target of Rs 625 per share thinking that it will have no impact on redemption of redeemable preference share.

    • Prefer Cipla, Aurobindo Pharma: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas is of the view that one may prefer Cipla and Aurobindo Pharma from pharma space.

    • Buy Cipla, Bank fo India, HPCL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Cipla, Bank fo India and HPCL.

    • Go long in M&M; Cipla can slide to Rs 555: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends going long in Mahindra and Mahindra and feels that Cipla can slide to Rs 555.

    • Dr Reddy's Labs top pick on decline, says Sanjiv Bhasin

      Sanjiv Bhasin of IIFL is of the view that Dr Reddy's Labs is the top pick on decline along with Cipla.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347